Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M.C. Lalanne"'
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 23:8-12
This model of arterial thrombosis induced by laser was used to evaluate the effect of aspirin (Aspegic®) on embolization. A partial occlusion was induced in small mesenteric arterioles (diameter 35-40 μm) with an Argon Laser. The laser induced the
Publikováno v:
Thrombosis Research. 65:33-43
Venous endothelium is able to release in vitro substances which modifies platelet aggregation. A vascular fragment incubated in Michaelis buffer (pH 7.30), aliquoted and tested on platelet-rich-plasma partially inhibits the aggregometry parameters. A
The role of essential vitamins in the development of thrombosis and hemorrhage-an experimental study
Publikováno v:
Thrombosis Research. 65:45-54
To evaluate the action of essential vitamins on hemorrhage, coagulation and thrombosis, a multivitaminized solution was daily administered at three different doses for two weeks to male Wistar rats. Two experimental models were carried out: a venous
Publikováno v:
Thrombosis Research. 64:263-272
Immuno-potent drugs are largely used in human medicine. The aim of this study was to determine the role of two immuno-modulators (sodium diethyl-dithiocarbamate, RU 41 740) and two immuno-suppressors (methylprednisolone, cyclosporin A) alone or in as
Autor:
Kevin A. Mitchell, M. Spannagl, Melitta Just, Mark D. Talbot, J. Bichler, Ron Almquist, Paul H. Johnson, Cris Olsen, M. Koehler, Robert B. Wallis, F. Doutremepuich, C. Vigneron, G. Pindur, M. Siebeck, F. Markwardt, E. Wenzel, Michael Wallock, F.A. Ofosu, Ch. Rauschenbach, J.W. Fenton, Jawed Fareed, K. Stocker, G. Nowak, H. Bichler, H. Fritz, Fritz Markwardt, B. Schulz, J. Walenga, Keith D. Butler, C.M. Kirchmaier, Richard C. Winant, Michael Koza, Dominique Tripier, Ping Sze, K. Narayanan, M.D. Liang, W. Schramm, Christopher M. Lees, K. Rübsamen, P. Zeiller, Jerome B. Lazar, H. Lill, William S. Fields, E. Glusa, M. Basic-Micic, C. Kirchmaier, John Ambler, Morris F. Tweed, V. Eschenfelder, A. Morin, Peter Underhill, E. Bucha, W. Raake, B. Fichtl, G.B. Villanueva, O.K. Bellinger, H. Elling, K. Krupinski, C. Doutremepuich, Debra Hoppensteadt, B. Braun, Dirk Seiffge, Mike Koza, M.C. Lalanne, H.K. Breddin, Debra Hudson, J. Stürzebecher, M. Heiden, J.M. Walenga, M. Marchand-Arvier, Roque Pifarre, Robin F. Peters, Jeanine M. Walenga, K. Breddin, R.J. Klauser, J.M. Maraganore, J. Fareed
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 21:I-IV
Publikováno v:
Thrombosis Research. 59:439-447
Heparin and its fractions have often been tested on fresh experimental thrombosis. However in human clinic, drugs are administered not on fresh, but rather on old constituted thrombi. In order to evaluate the effects of antithrombotic agents in these
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 20:99-105
Aspirin at very ultra low dosage was tested in healthy volunteers (n = 20) in a randomized, double-blind and placebo-controlled trial. The results showed a bleeding time reduction (p < 0.05) in volunteers having previously ingested aspirin. Platelet
Publikováno v:
Thrombosis research. 66(6)
Publikováno v:
Thrombosis research. 63(1)
Heparin fractions are antithrombotic drugs prescribed for preventive treatment but their efficacy must be optimized to permit curative use without side effects. The present study was performed on 144 rats receiving a low molecular weight heparin (L.M
Autor:
Jeanine M. Walenga, F. Doutremepuich, C. Doutremepuich, Jawed Fareed, H.K. Breddin, M.C. Lalanne
Publikováno v:
Haemostasis. 21
Three recombinant hirudins (r-hirudins) produced by genetic processes from Escherichia coli and yeast were studied. r-Hirudins could be an alternative treatment to heparin; so, the antithrombotic activity of these drugs should be compared to heparin,